Signal from the log
WhiteLab Genomics
26 M$ · Series B · France · Biotech
WhiteLab Genomics conçoit par intelligence artificielle les vecteurs qui transportent une thérapie génique jusqu'aux bonnes cellules, virus AAV et nanoparticules lipidiques, puis les teste chez l'animal. Avec l'Institut du Cerveau, elle a obtenu des AAV qui franchissent la barrière du cerveau sans signal détectable dans le foie. AVP mène cette série B.
Article
Announced on , logged by the watch of 6 October 2026.
- Operation
- Funding round
- Announced amount
- 26 M$
- Stage
- Series B
- Country
- France
- Sector
- Biotech
What the log says
Editorial note, in French
Sujet traité. L'article donne les sources et la position de Bolus.
The investors
Led by AVP , with Yaday Health , Blast Club
Provenance
Source eu-startups,sifted
Logged on 6 October 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Article The operation led to an article, with its sources checked one by one.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.